Get the Stockscreener App
0.754
3.86%
0.028
Palisade Bio Inc stock is traded at $0.754, with a volume of 207.05K.
It is up +3.86% in the last 24 hours and down -12.33% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$0.726
Open:
$0.711
24h Volume:
207.05K
Relative Volume:
0.11
Market Cap:
$6.88M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.0539
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
-5.87%
1M Performance:
-12.33%
6M Performance:
-20.06%
1Y Performance:
-79.00%
1-Day Range:
$0.7097
$0.754
1-Week Range:
$0.70
$0.82
52-Week Range:
$0.60
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
0.754 | 7.46M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc Stock (PALI) Latest News
What’s the recovery path for long term holders of Palisade Bio Inc.2025 Market Overview & Fast Moving Stock Trade Plans - Newser
Measuring Palisade Bio Inc.’s beta against major indices2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
Volume spikes in Palisade Bio Inc. stock – what they meanMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment - MSN
Published on: 2025-08-20 09:24:12 - beatles.ru
Historical volatility pattern of Palisade Bio Inc. visualizedPortfolio Profit Report & Breakout Confirmation Alerts - Newser
Full technical analysis of Palisade Bio Inc. stock2025 Market Overview & Community Consensus Picks - Newser
Is Palisade Bio Inc. forming a bottoming baseJuly 2025 Momentum & Expert Curated Trade Setup Alerts - Newser
Is Palisade Bio Inc. stock ready for a breakout2025 AllTime Highs & Stepwise Trade Signal Implementation - Newser
Regression Model Predicts Rangebound Movement in Palisade Bio Inc.Market Performance Summary & AI Enhanced Trading Signals - 선데이타임즈
Palisade Bio Inc. stock volume spike explained2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Using Python tools to backtest Palisade Bio Inc. strategiesTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Palisade Bio Inc. Builds Base for Possible ReboundDay Trade & Technical Analysis for Trade Confirmation - newsimpact.co.kr
Momentum Screeners Rank Palisade Bio Inc. in Top 5 TodayWeekly Stock Analysis & Safe Capital Preservation Plans - kangso.co.kr
Why Palisade Bio Inc. is moving today2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser
Is Palisade Bio Inc. stock poised for growth2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Institutional scanner results for Palisade Bio Inc.Market Performance Recap & Capital Efficiency Focused Ideas - Newser
How to monitor Palisade Bio Inc. with trend dashboardsMarket Rally & Free Community Supported Trade Ideas - Newser
Price Consolidation Hints at Upcoming Move in Palisade Bio Inc.Price Movement Prediction Analysis Plan - beatles.ru
Palisade Bio Files for 8.9M Share Registration for Selling Stockholders - AInvest
Applying Elliott Wave Theory to Palisade Bio Inc.July 2025 Snapshot & Daily Entry Point Alerts - Newser
Palisade Bio Inc. stock trendline breakdownWeekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
Q3 EPS Estimates for Palisade Bio Reduced by Analyst - Defense World
How sentiment analysis helps forecast Palisade Bio Inc.Portfolio Return Report & Long-Term Growth Plans - Newser
Palisade Bio registers 8.9M shares for resale by selling stockholders - MSN
Is It Too Late to Sell Palisade Bio Inc.2025 Price Action Summary & Daily Oversold Stock Bounce Ideas - thegnnews.com
Recovery Signals Appearing in Palisade Bio Inc. ChartsQuarterly Portfolio Review & Daily Stock Trend Watchlist - thegnnews.com
Heatmap analysis for Palisade Bio Inc. and competitorsTrade Analysis Summary & Target Return Focused Picks - Newser
What makes Palisade Bio Inc. stock price move sharplyQuarterly Growth Report & Fast Entry Momentum Trade Alerts - Newser
Palisade Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palisade Bio Inc Stock (PALI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):